Dupilumab as a treatment for bullous pemphigoid in a liver transplant recipient: A case report
Bullous pemphigoid is a common subepidermal autoimmune bullous disease that affects the skin and mucous membranes. It is more prevalent in the elderly, often resulting in significant morbidity and mortality. Bullous pemphigoid is rare in solid organ transplant recipients but presents unique challeng...
Saved in:
| Main Authors: | Sarah S. Rashid, P. Régine Mydlarski, Fatemeh Jafarian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-06-01
|
| Series: | SAGE Open Medical Case Reports |
| Online Access: | https://doi.org/10.1177/2050313X251350348 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dupilumab, corticosteroids and their combination for the treatment of bullous pemphigoid
by: Guirong Liang, et al.
Published: (2025-04-01) -
Cutaneous bacillary angiomatosis in the setting of immunosuppression: A rare case in a heart transplant recipient
by: Chloe Devoy, et al.
Published: (2025-07-01) -
Time to Disease Control with Dupilumab for Bullous Pemphigoid: A Systematic Review and Meta-analysis
by: Laurence Mainville, et al.
Published: (2025-05-01) -
Severe case of bullous pemphigoid associated with nivolumab responsive to combination therapy with dupilumab and omalizumab
by: Liana Victory, MB, BCh, BAO, MRCPI, et al.
Published: (2025-03-01) -
Concomitant use of dupilumab with glucocorticoid in bullous pemphigoid reduces disease severity: A preliminary study
by: Lingyu Hu, et al.
Published: (2023-07-01)